Skip to content

Fluorescent Antibody Assay for Viral Antigen in Serum/Plasma

Published: August 9, 2026Updated: August 16, 2026

This test uses a fluorescent antibody method to detect specific antigens from certain viruses in your blood. It helps identify active infection by detecting the virus’s proteins.

Quick summary

["Detects active viral infection in serum or plasma using fluorescence-based immunoassay."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
43851-5
Short code
FLUAV IgA Ser Ql
Synonyms
FLUAV IgA Ser Ql
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The test identifies the presence of viral antigens—specific proteins produced by certain viruses—within your blood. These antigens signal that the virus is actively multiplying in your body. This method is particularly useful for diagnosing infections where the virus is present but antibody levels may not yet be detectable.

How the Test Works

A fluorescent antibody binds to the viral antigens in your serum or plasma sample. If the virus is present, the binding triggers a detectable fluorescent signal, which is measured to confirm infection. This technique is highly sensitive and can detect low levels of viral proteins.

Common Uses

This test is often used for diagnosing acute viral infections, such as certain respiratory or gastrointestinal viruses, where early detection is critical. It may also be used in research or specialized clinical settings to monitor viral load in specific patient populations.

Sample Collection and Preparation

Blood is drawn from a vein, typically in the arm, and processed into either serum (after clotting) or plasma (after centrifugation). The sample is then analyzed in a laboratory using the fluorescent antibody technique to detect viral antigens.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Viral Antigen Detection (Serum/Plasma)

Frequently asked questions

Why might my doctor order this test?
Your doctor may recommend this test if you have symptoms suggestive of a viral infection (e.g., fever, fatigue, respiratory issues) or if you are at higher risk for certain viral illnesses (e.g., immunocompromised individuals, travelers to endemic regions).
What does a positive result mean?
A positive result indicates the presence of viral antigens in your blood, suggesting active viral infection. This does not necessarily mean you will develop symptoms immediately, but it confirms the virus is present and may require further medical evaluation or treatment.
Are there any risks or side effects from this test?
The most common side effect is mild bruising or soreness at the injection site from the blood draw. Rarely, there may be a slight reaction to the needle, but most people tolerate the procedure well. No other risks are associated with this specific test.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy